Drug Coated Balloons vs Plain Balloons for the Management of Dysfunctional Dialysis Fistula
Primary Purpose
Dysfunctional Dialysis Arteriovenous Fistula
Status
Terminated
Phase
Not Applicable
Locations
Saudi Arabia
Study Type
Interventional
Intervention
Vessel preparation with angioplasty
Plain balloon angioplasty
Drug coated balloon angioplasty
Sponsored by
About this trial
This is an interventional treatment trial for Dysfunctional Dialysis Arteriovenous Fistula
Eligibility Criteria
Inclusion Criteria:
Inclusion criteria
- >18 year old
- Dysfunctional dialysis fistula
- Radiocephalic
- Brachiocephalic
- Brachiobasilic
Clinical criteria for diagnosis of dysfunctional fistula:
- Swelling of the fistula limb
- Prolonged bleeding after withdrawing access needles
- Abnormal pulsations or weak thrill.
- Functional criteria for the diagnosis of dysfunctional criteria:
- Arteriovenous fistula is unable to deliver dialysis blood flow (Qb) of equal to or more than 300 ml/min and/or access recirculation of more than 10% on at least two occasions,
- A rising trend of venous pressure or excessive negative arterial pressure, and/or unable to deliver a Kt/v of 1.2 or more.
- Non-thrombosed
Exclusion Criteria:
- Dysfunctional arteriovenous (AV) grafts
- Thrombosed fistulas
- Intra-stent stenosis
- Stenoses not responding to balloon angioplasty and requiring stenting.
- Stenosis less than 50%
- Surgical intervention that excludes the treatment segment from the access circuit
- Systemic or local (to the fistula) infection treated for less than 10 days prior to the study procedure
- Location of isolated stenosis central to the thoracic inlet.
- Women who are breastfeeding, pregnant or are intending to become pregnant
- Known hypersensitivity or contraindication to contrast medium which cannot be adequately premeditated.
- Sensitivities to heparin, aspirin, other anticoagulant/antiplatelet therapies, and/or paclitaxel
Sites / Locations
- King ABdulaziz Medical City
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Drug coated balloon angioplasty
Plain balloon angioplasty
Arm Description
Vessel preparation with Pre dilatation Vessel treatment with Drug-coated balloon
Vessel preparation with Pre dilatation Vessel treatment with additional Plain balloon angioplasty:
Outcomes
Primary Outcome Measures
AVF circuit patency
Dialysis adequacy to be assessed based on functional criteria
Secondary Outcome Measures
Technical success
<30% residual stenosis without postdilation
Access circuit dysfunction free survival
Time to event based on functional criteria
Target lesion restenosis free survival
Time to event in case of new lesion causes circuit dysfunction
Number of participants with treatment-related adverse events
Number of participants with treatment-related adverse events as assessed by the Society of Interventional Radiology Clinical Practice Guidelines
Full Information
NCT ID
NCT03189667
First Posted
June 1, 2017
Last Updated
April 28, 2019
Sponsor
King Abdullah International Medical Research Center
1. Study Identification
Unique Protocol Identification Number
NCT03189667
Brief Title
Drug Coated Balloons vs Plain Balloons for the Management of Dysfunctional Dialysis Fistula
Official Title
Drug Coated Balloons vs Plain Balloons for the Management of Dysfunctional Dialysis Fistula
Study Type
Interventional
2. Study Status
Record Verification Date
April 2019
Overall Recruitment Status
Terminated
Why Stopped
slow recruitment and recent concerns of safety of Paclitaxel coated balloons and associated increased risk death
Study Start Date
October 15, 2017 (Actual)
Primary Completion Date
February 5, 2019 (Actual)
Study Completion Date
February 5, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
King Abdullah International Medical Research Center
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Compare the effectiveness of drug-coated balloons to plain balloon angioplasty in reducing stenosis rates in dialysis arteriovenous fistulas (AVFs).
Detailed Description
Objectives of the Study:
Hypothesis: Drug-coated balloons improve functional and patency outcomes of failing/dysfunctional hemodialysis fistulas compared to plain uncoated balloons
Aim of the Study:
Compare the effectiveness of drug-coated balloons to plain balloon angioplasty in reducing stenosis rates in dialysis AVFs.
Specific Objectives:
Primary functional endpoint: Access circuit patency based on functional criteria at 12 month.
Primary safety endpoint: Peri procedural complication rate
Secondary endpoints:
Technical success (<30% residual stenosis without postdilation)
Access circuit dysfunction free survival (Time to event) based on functional criteria
Target lesion restenosis free survival (Time to event) (in case of new lesion causes circuit dysfunction)
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dysfunctional Dialysis Arteriovenous Fistula
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Open label randomized clinical trial
Masking
None (Open Label)
Allocation
Randomized
Enrollment
23 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Drug coated balloon angioplasty
Arm Type
Experimental
Arm Description
Vessel preparation with Pre dilatation
Vessel treatment with Drug-coated balloon
Arm Title
Plain balloon angioplasty
Arm Type
Active Comparator
Arm Description
Vessel preparation with Pre dilatation
Vessel treatment with additional Plain balloon angioplasty:
Intervention Type
Device
Intervention Name(s)
Vessel preparation with angioplasty
Intervention Description
Vessel preparation with Pre dilatation:
All lesions to be predilated with high pressure balloons until waist is obliterated.
At least two minutes dilatation.
Balloon sizing: not to exceed the average diameter of adjacent normal appearing non-aneurysmal segments by more than 25%.
Multiple lesions:
To be treated with single balloon if possible.
To be treated with multiple inflation if cannot be covered with single balloon.
Intervention Type
Device
Intervention Name(s)
Plain balloon angioplasty
Intervention Description
Plain balloon angioplasty
Vessel treatment with additional Plain balloon angioplasty:
Inflation to nominal pressure for at least 1 minute.
Balloon size: similar to predilation balloon.
Intervention Type
Device
Intervention Name(s)
Drug coated balloon angioplasty
Intervention Description
Lutonix® Drug Coated Balloon: The balloon is coated with a specialized formulation that includes the drug, paclitaxel. The paclitaxel coating is evenly distributed across the working length of the balloon at a surface concentration of 2 μg/mm2. The key functional characteristic of the formulation is to allow for release of paclitaxel to the tissue of the vascular wall during inflation.
Inflation to nominal pressure for at least 1 minute.
Balloon size: similar to the predilation balloon.
New drug coated balloon will be required for each lesion.
Primary Outcome Measure Information:
Title
AVF circuit patency
Description
Dialysis adequacy to be assessed based on functional criteria
Time Frame
12 month
Secondary Outcome Measure Information:
Title
Technical success
Description
<30% residual stenosis without postdilation
Time Frame
intra procedural
Title
Access circuit dysfunction free survival
Description
Time to event based on functional criteria
Time Frame
12 month
Title
Target lesion restenosis free survival
Description
Time to event in case of new lesion causes circuit dysfunction
Time Frame
12 month
Title
Number of participants with treatment-related adverse events
Description
Number of participants with treatment-related adverse events as assessed by the Society of Interventional Radiology Clinical Practice Guidelines
Time Frame
12 month following the procedure
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Inclusion criteria
>18 year old
Dysfunctional dialysis fistula
Radiocephalic
Brachiocephalic
Brachiobasilic
Clinical criteria for diagnosis of dysfunctional fistula:
Swelling of the fistula limb
Prolonged bleeding after withdrawing access needles
Abnormal pulsations or weak thrill.
Functional criteria for the diagnosis of dysfunctional criteria:
Arteriovenous fistula is unable to deliver dialysis blood flow (Qb) of equal to or more than 300 ml/min and/or access recirculation of more than 10% on at least two occasions,
A rising trend of venous pressure or excessive negative arterial pressure, and/or unable to deliver a Kt/v of 1.2 or more.
Non-thrombosed
Exclusion Criteria:
Dysfunctional arteriovenous (AV) grafts
Thrombosed fistulas
Intra-stent stenosis
Stenoses not responding to balloon angioplasty and requiring stenting.
Stenosis less than 50%
Surgical intervention that excludes the treatment segment from the access circuit
Systemic or local (to the fistula) infection treated for less than 10 days prior to the study procedure
Location of isolated stenosis central to the thoracic inlet.
Women who are breastfeeding, pregnant or are intending to become pregnant
Known hypersensitivity or contraindication to contrast medium which cannot be adequately premeditated.
Sensitivities to heparin, aspirin, other anticoagulant/antiplatelet therapies, and/or paclitaxel
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mohammad Arabi, MD
Organizational Affiliation
King Abdulaziz Medical City
Official's Role
Principal Investigator
Facility Information:
Facility Name
King ABdulaziz Medical City
City
Riyadh
ZIP/Postal Code
11426
Country
Saudi Arabia
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Drug Coated Balloons vs Plain Balloons for the Management of Dysfunctional Dialysis Fistula
We'll reach out to this number within 24 hrs